Investment Thesis
Masimo demonstrates strong operational fundamentals with exceptional 62.1% gross margins and 19.2% operating margins, coupled with conservative leverage (0.57x Debt/Equity) and excellent liquidity (2.68x current ratio). However, the material divergence between revenue growth (9.4%) and net income growth (50.3%) raises sustainability concerns about earnings quality, and low ROE (7.2%) suggests capital deployment inefficiency that must improve.
Strengths
- Exceptional gross margin of 62.1% indicating strong competitive moat and pricing power in medical device market
- Conservative balance sheet with Debt/Equity ratio of 0.57x, Interest Coverage of 6.5x, and Current Ratio of 2.68x providing financial flexibility
- Solid operating margin of 19.2% and net margin of 14.1% demonstrating operational efficiency and cost control
- Positive free cash flow generation of $41M with low capital intensity (CapEx only $4.3M), enabling shareholder returns or debt reduction
- Operating leverage evident in earnings growth (+50.3% YoY) outpacing revenue growth (+9.4% YoY)
Risks
- Moderate revenue growth of 9.4% limits business expansion and future earning potential sustainability
- Significant earnings growth-to-revenue growth divergence (50.3% vs 9.4%) suggests one-time gains, unsustainable margin expansion, or earnings quality concerns
- Low ROE of 7.2% and ROA of 3.5% indicate inefficient capital deployment despite profitable operations
- Operating cash flow to net income conversion ratio suggests potential future cash flow pressure or earnings quality issues
Key Metrics to Watch
- Revenue growth rate acceleration and sustainability beyond 9.4% to validate long-term business momentum
- Gross and operating margin trends to confirm whether current levels are maintainable or inflated by temporary factors
- Return on Equity trajectory improvement to demonstrate better capital efficiency and utilization
Financial Metrics
Revenue
403.6M
Net Income
57.1M
EPS (Diluted)
$1.09
Free Cash Flow
41.0M
Total Assets
1.6B
Cash
124.6M
Profitability Ratios
Gross Margin
62.1%
Operating Margin
19.2%
Net Margin
14.1%
ROE
7.2%
ROA
3.5%
FCF Margin
10.2%
Balance Sheet & Liquidity
Current Ratio
2.68x
Quick Ratio
1.45x
Debt/Equity
0.57x
Debt/Assets
52.0%
Interest Coverage
6.45x
Long-term Debt
452.0M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-07T09:45:11.004227 |
Data as of: 2026-04-04 |
Powered by Claude AI